Clinical trial

A Clinical Study With MT-102 in Subjects With Cancer Cachexia

NCT01238107

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-04-01

PhasePHASE2

Study timeline

Study start (unknown)2011-04-01Date precision: month

Registry last updated2014-09-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cancer Cachexiaunresolved

Interventions

MT-102DRUG

Sponsors & collaborators

Akamis Biolead sponsor

Veeda Oncologycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01238107 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.